| Outcome | Apixaban N = 2609 n (%) |
Enoxaparin/Warfarin N = 2635 n (%) |
RR (95% CI) |
|---|---|---|---|
| VTE or VTE-related death* | 59 (2.3) | 71 (2.7) | 0.84 (0.60-1.18) |
| DVT† | 22 (0.8) | 35 (1.3) | |
| PE† | 27 (1.0) | 25 (0.9) | |
| VTE-related death | 12 (0.4) | 16 (0.6) | |
| VTE or all-cause death | 84 (3.2) | 104 (4.0) | 0.82 (0.61-1.08) |
| VTE or CV-related death | 61 (2.3) | 77 (2.9) | 0.80 (0.57-1.11) |